TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name 4'-Hydroxywogonin, Wortmannin
Phytochemical Name 4'-Hydroxywogonin (PubChem CID: 5322078 )
Anticancer drug Name Wortmannin (PubChem CID: 312145 )
Structure of
Phytochemical		 2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug		 2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 152
Ref_1
Pair Name 4'-Hydroxywogonin, Wortmannin
Disease Info [ICD-11: 2B91.Z] Colorectal cancer Investigative
Biological Phenomena Inhibition-->Angiogenesis
Gene Regulation Down-regulation Phosphorylation PIK3CA hsa5290
Down-regulation Phosphorylation AKT1 hsa207
Down-regulation Expression VEGFA hsa7422
In Vitro Model SW620 Colon adenocarcinoma Homo sapiens (Human) CVCL_0547
Result 4'-HW decreased the viability and reduced angiogenesis in CRC, which was associated with downregulation of VEGF-A expression by disrupting the PI3K/AKT pathway. Our discoveries suggested 4'-HW as a promising anticancer agent against CRC targeting angiogenesis.
03. Reference
No. Title Href
1 4'-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chem Biol Interact. 2018 Dec 25;296:26-33. doi: 10.1016/j.cbi.2018.09.003. Click
It has been 465672 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP